Pharmaceutical News

RSS

Misuse of ADHD stimulant medications declines sharply among young adults

Misuse of stimulant medications for attention deficit hyperactivity disorder (ADHD) has declined sharply.

9 Jul 2026

University of Malaga scientists find way to improve morphine treatments

Scientists at the Department of Cell Biology of the University of Malaga have taken a step forward in the search for more effective treatments for pain with a new study that continues advancing in mitigating the addictive effects of morphine -one of the main drugs used for this purpose- as well as the development of analgesic tolerance to this drug.

9 Jul 2026

Antihistamines show modest benefits for long Covid fatigue treatment

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid fatigue among people receiving care from specialist long Covid clinics, according to new findings from a large clinical trial led by UCL and UCLH.

8 Jul 2026

Only one in 10 Australians know the Black Triangle safety symbol

Research highlights gaps in awareness of Australia's Black Triangle Scheme, suggesting strategies to enhance understanding and reporting of adverse drug events.

8 Jul 2026

Most hospital readmissions after heart failure are not heart-related

A study reveals that non-cardiovascular medications increase hospital readmission risks in heart failure patients, highlighting the need for better management.

8 Jul 2026

HonorHealth offers new drug that doubles pancreatic cancer survival

Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation to offer a new drug, Daraxonrasib, that based on early data nearly doubles the average survival time of patients with pancreatic cancer.

7 Jul 2026

Hormonal contraceptives may raise binge eating risk in women

Birth control pills are safe and effective for millions of women, but researchers are still working to understand how the hormones they contain may influence eating behavior.

6 Jul 2026

McMaster researchers uncover why statins cause painful muscle side effects

Millions of people rely on statins - a medication used to lower cholesterol and reduce the risk of heart attack and stroke.

6 Jul 2026

Study reveals why “linked with” and “increases risk” may mean the same to many readers

A preregistered experiment of 1,957 adults found that people endorsed “is linked with” and “increases the risk of” statements about Tylenol use in pregnancy and autism at similar rates. The findings suggest that poll responses using increased-risk language should not automatically be interpreted as evidence that the public believes Tylenol directly causes autism.

5 Jul 2026

Can ibuprofen improve drug-resistant tuberculosis treatment?

While ibuprofen reduced inflammatory markers in drug-resistant TB patients, it did not enhance treatment outcomes, indicating the need for further research.

3 Jul 2026

Insilico Medicine partners with Takeda for AI-driven drug discovery

Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas.

2 Jul 2026

Widely used pandemic pharmaceuticals harm marine aquatic ecosystems

A new study published in New Contaminants suggests that several drugs widely used during the COVID-19 pandemic can be toxic to marine organisms, even at relatively low concentrations.

2 Jul 2026

KFF poll finds vaccine myths reach many Americans but convince few

KFF’s 2026 tracking poll found that many U.S. adults have heard common vaccine myths, including false claims about MMR, COVID-19, mRNA vaccines, and measles vaccines. Fewer adults strongly believe these myths, but a large, uncertain “malleable middle” remains, especially among those without a trusted health care provider, frequent social media users, some AI health-information users, and parents who delayed or skipped childhood vaccines.

1 Jul 2026

Scientists urge caution over psychedelics as ADHD treatment

In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD.

1 Jul 2026

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However, among adults without type 2 diabetes, tirzepatide was linked to higher recorded hazards of anxiety and insomnia than semaglutide, underscoring the need for cautious monitoring.

1 Jul 2026

Melatonin may safely reduce chronic musculoskeletal pain, study finds

A sleep supplement widely used to treat insomnia could help reduce reliance on some of the most common and potentially harmful pain medications, new research from the University of Sydney suggests.

30 Jun 2026

Many pharmaceutical active ingredients can switch to PFAS-free alternatives

Certain medicines contain per- and polyfluorinated alkyl compounds, known as PFAS, which are causing increasing environmental harm due to their long-lasting effects.

30 Jun 2026

New Alzheimer drug lecanemab brings modest benefits and high risks

Canada recently approved lecanemab to treat early Alzheimer disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex.

29 Jun 2026

Scientists discover 70 existing drugs that block deadly hantavirus infections

Researchers screened over 5,000 compounds and successfully pinpointed 70 existing drugs, including unexpected beta-lactam antibiotics, that effectively suppress Puumala orthohantavirus infection in human cells. This milestone drug-repurposing study provides an immediate, fast-tracked pipeline for developing the first approved treatments against life-threatening hantavirus diseases.

28 Jun 2026

Nasal viruses may drive allergic rhinitis, and ribavirin shows early promise as a targeted spray treatment

Nasal commensal viruses may worsen allergic rhinitis by activating type I IFN-linked neutrophils and NET formation. Ribavirin reduced nasal viral abundance and improved symptoms in mice and in a small phase 2 trial.

28 Jun 2026